| Name | Title | Contact Details |
|---|---|---|
Gareth Hooper |
Chief Information Officer | Profile |
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Blessing Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Blessing Hospital is based in Quincy, IL. You can find more information on Blessing Hospital at www.blessinghospital.com
HealthCare IT is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BIOCIUS Life Sciences is a Wakefield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In 1998, RPS began building the foundation for the PRO model in anticipation of evolving clinical strategies within Sponsor companies. By integrating its personnel and systems with those of Sponsor companies, RPS has helped industry leaders achieve significant cost savings, flexible program staffing, and standardized system operations on a global scale.